Kura Oncology Inc
KURA
Company Profile
Business description
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company’s pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
Contact
12730 High Bluff Drive
Suite 400
San DiegoCA92130
USAT: +1 858 500-8800
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
192
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,774.80 | 86.80 | 1.00% |
| CAC 40 | 7,615.99 | 78.42 | 1.04% |
| DAX 40 | 23,644.21 | 375.20 | 1.61% |
| Dow JONES (US) | 43,011.75 | 429.97 | 1.01% |
| FTSE 100 | 8,758.99 | 0.95 | 0.01% |
| HKSE | 24,177.07 | 487.94 | 2.06% |
| NASDAQ | 19,905.30 | 274.33 | 1.40% |
| Nikkei 225 | 38,790.56 | 436.47 | 1.14% |
| NZX 50 Index | 12,467.48 | 65.17 | -0.52% |
| S&P 500 | 6,084.29 | 59.12 | 0.98% |
| S&P/ASX 200 | 8,555.50 | 80.60 | 0.95% |
| SSE Composite Index | 3,420.57 | 38.98 | 1.15% |